2 results
Approved WMORecruiting
Primary Objective: Evaluation of effectiveness (AHI using PSG) of SPT when compared to MRA in patients with mild to moderate positional dependent obstructive sleep apnea (POSA) in a non-inferiority setting for a short (3 months) and longterm (12…
Approved WMORecruiting
Primary Objectives- Determine the MTD of pixantrone, rituximab (only in CD20 positive tumors), etoposide, and bendamustine in *fit' patients with rel aNHL of B- or T-cell phenotype.- Evaluate the ORR and PFS using the combination of pixantrone…